The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T > C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients

Molecular Immunology

Volumn 44, Issue 4, 2007, Pages 648-655

  Laki, Judit ^a   Kiszel, Petra ^a   Vatay, Ágnes ^a   Blaskó, Bernadett ^a   Kovács, Margit ^a   Körner, Anna ^b   Madácsy, László ^b   Blatniczky, László ^c   Almássy, Zsuzsa ^d   Szalai, Csaba ^d   Rajczy, Katalin ^e   Pozsonyi, Éva ^e   Karádi, István ^a   Fazakas, Ádám ^a   Hosszúfalusi, Nóra ^a   Pánczél, Pál ^a   Arason, Gudmundur J ^f   Wu, Yee Ling ^g   Zhou, Bi ^g   Yang, Yan ^g   Yu, C Yung ^g   Füst, George ^a   more..

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b 1st Department of Pediatrics   (Hungary)

^c Buda Children's Hospital   (Hungary)

^d HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

^e NATIONAL MEDICAL CENTER   (Hungary)

^f LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^g OHIO STATE UNIVERSITY   (United States)

Author keywords

8.1 AH; Ancestral haplotype; Diabetes; HemoglobinA1C; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HEMOGLOBIN A1C; HLA ANTIGEN; HLA DQ2 ANTIGEN; HLA DR ANTIGEN; HLA DR17 ANTIGEN; HLA DR3 ANTIGEN; INSULIN; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CAUCASIAN; CHROMOSOME 6; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ALLELES; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEMOGLOBIN A, GLYCOSYLATED; HLA ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC;

EID: 33747843105     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.01.011     Document Type: Article

References (30)

1. Abraham L.J., French M.A., and Dawkins R.L. Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin. Exp. Immunol. 92 (1993) 14-18
2. Alper C.A., and Larsen C.E. Immunogenetics human immunogenetics. Curr. Opin. Immunol. 16 (2004) 623-625
3. Bierhaus A., Schiekofer S., Schwaninger M., Andrassy M., Humpert P.M., Chen J., Hong M., Luther T., Henle T., Kloting I., Morcos M., Hofmann M., Tritschler H., Weigle B., Kasper M., Smith M., Perry G., Schmidt A.M., Stern D.M., Haring H.U., Schleicher E., and Nawroth P.P. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 50 (2001) 2792-2808
4. Blanchong C.A., Zhou B., Rupert K.L., Chung E.K., Jones K.N., Sotos J.F., Zipf W.B., Rennebohm R.M., and Yung Y.C. Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J. Exp. Med. 191 (2000) 2183-2196
5. Bucciarelli L.G., Wendt T., Rong L., Lalla E., Hofmann M.A., Goova M.T., Taguchi A., Yan S.F., Yan S.D., Stern D.M., and Schmidt A.M. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol. Life Sci. 59 (2002) 1117-1128
6. Candore G., Colucci A.T., Modica M.A., and Caruso C. HLA-B8, DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2. Immunopharmacol. Immunotoxicol. 13 (1991) 551-561
7. Candore G., Lio D., Colonna R.G., and Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun. Rev. 1 (2002) 29-35
8. Candore G., Modica M.A., Lio D., Colonna-Romano G., Listi F., Grimaldi M.P., Russo M., Triolo G., Accardo-Palumbo A., Cuccia M.C., and Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed. Pharmacother. 57 (2003) 274-277
9. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16 (1998) 545-568
10. Caruso C., Candore G., Colucci A.T., Cigna D., Modica M.A., Tantillo G., and Salerno A. Natural killer and lymphokine-activated killer activity in HLA-B8, DR3-positive subjects. Hum. Immunol. 38 (1993) 226-230
11. Daly M.J., Rioux J.D., Schaffner S.F., Hudson T.J., and Lander E.S. High-resolution haplotype structure in the human genome. Nat. Genet. 29 (2001) 229-232
12. Day C.P., Grove J., Daly A.K., Stewart M.W., Avery P.J., and Walker M. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 41 (1998) 430-434
13. Franciotta D., Cuccia M., Dondi E., Piccolo G., and Cosi V. Polymorphic markers in MHC class II/III region: a study on Italian patients with myasthenia gravis. J. Neurol. Sci. 190 (2001) 11-16
14. Garcia-Merino A., Alper C.A., Usuku K., Marcus-Bagley D., Lincoln R., Awdeh Z., Yunis E.J., Eisenbarth G.S., Brink S.J., and Hauser S.L. Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Hum. Immunol. 50 (1996) 11-21
15. Gleeson M.H., Walker J.S., Wentzel J., Chapman J.A., and Harris R. Human leucocyte antigens in Crohn's disease and ulcerative colitis. Gut 13 (1972) 438-440
16. Globocnik P.M., Steblovnik K., Peterlin B., and Petrovic D. The -429T/C and -374T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes. Klin. Monatsbl. Augenheilkd. 220 (2003) 873-876
17. Hudson B.I., Stickland M.H., Futers T.S., and Grant P.J. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50 (2001) 1505-1511
18. JiXiong X., BiLin X., MingGong Y., and ShuQin L. -429T/C and -374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diab. Care 26 (2003) 2696-2697
19. Kankova K., Stejskalova A., Hertlova M., and Znojil V. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol. Dial. Transplant. 20 (2005) 1093-1102
20. Lander H.M., Tauras J.M., Ogiste J.S., Hori O., Moss R.A., and Schmidt A.M. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem. 272 (1997) 17810-17814
21. Lio D., Candore G., Colombo A., Colonna R.G., Gervasi F., Marino V., Scola L., and Caruso C. A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8, DR3 positive subjects: implications for autoimmunity. Hum. Immunol. 62 (2001) 705-713
22. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215
23. Miretti M.M., Walsh E.C., Ke X., Delgado M., Griffiths M., Hunt S., Morrison J., Whittaker P., Lander E.S., Cardon L.R., Bentley D.R., Rioux J.D., Beck S., and Deloukas P. A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76 (2005) 634-646
24. Modica M.A., Zambito A.M., Candore G., and Caruso C. Markers of T lymphocyte activation in HLA-B8, DR3 positive individuals. Immunobiology 181 (1990) 257-266
25. Pettersson-Fernholm K., Forsblom C., Hudson B.I., Perola M., Grant P.J., and Groop P.H. The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 52 (2003) 891-894
26. Pociot F., Ronningen K.S., and Nerup J. Polymorphic analysis of the human MHC-linked heat shock protein 70 (HSP70-2) and HSP70-Hom genes in insulin-dependent diabetes mellitus (IDDM). Scand. J. Immunol. 38 (1993) 491-495
27. Price P., Witt C., Allcock R., Sayer D., Garlepp M., Kok C.C., French M., Mallal S., and Christiansen F. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167 (1999) 257-274
28. Van Den Berg-Loonen E.M., Dekker-Saeys B.J., Meuwissen S.G., Nijenhuis L.E., and Engelfriet C.P. Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases. J. Immunogenet. 4 (1977) 167-175
29. Yeh C.H., Sturgis L., Haidacher J., Zhang X.N., Sherwood S.J., Bjercke R.J., Juhasz O., Crow M.T., Tilton R.G., and Denner L. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. Diabetes 50 (2001) 1495-1504
30. Yu C.Y., and Whitacre C.C. Sex, MHC and complement C4 in autoimmune diseases. Trends Immunol. 25 (2004) 694-699